Combining CT and nuclear: a winning hybrid team by Kaufmann, P A & Gaemperli, O
University of Zurich
Zurich Open Repository and Archive
Winterthurerstr. 190
CH-8057 Zurich
http://www.zora.uzh.ch
Year: 2009
Combining CT and nuclear: a winning hybrid team
Kaufmann, P A; Gaemperli, O
Kaufmann, P A; Gaemperli, O (2009). Combining CT and nuclear: a winning hybrid team. Journal of Nuclear
Cardiology, 16(2):170-172.
Postprint available at:
http://www.zora.uzh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.uzh.ch
Originally published at:
Journal of Nuclear Cardiology 2009, 16(2):170-172.
Kaufmann, P A; Gaemperli, O (2009). Combining CT and nuclear: a winning hybrid team. Journal of Nuclear
Cardiology, 16(2):170-172.
Postprint available at:
http://www.zora.uzh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.uzh.ch
Originally published at:
Journal of Nuclear Cardiology 2009, 16(2):170-172.
EDITORIAL 
 
Combining CT and Nuclear – a Winning Hybrid Team 
 
 
Philipp A Kaufmann, MD and Oliver Gaemperli, MD 
 
 
 
From the Nuclear Cardiology Division, University Hospital Zurich, Switzerland 
 
 
 
Address for correspondence  
and reprint requests: 
 
Philipp A. Kaufmann MD 
Director Nuclear Cardiology 
Cardiovascular Center 
University Hospital Zurich NUK C 42 
Raemistrasse 100 
CH-8091 Zurich 
Switzerland  
Tel.  +41 44 255 35 55 
Fax +41 44 255 44 14 
Email: pak@usz.ch
  
 
 
 1
An important aspect in the management of patients with coronary artery disease 
(CAD) is consideration of the duality of morphology and function.(1) Hence, a 
comprehensive assessment of CAD should include both information on coronary 
lesion morphology and myocardial perfusion, and ideally both should be obtained 
noninvasively to allow for optimal clinical decision making and reduce the risk 
inherent in invasive diagnostic procedures. While perfusion imaging has been 
feasible by noninvasive means using myocardial perfusion scintigraphy for more than 
three decades, the concept of noninvasive coronary angiography has only recently 
gained clinical acceptance by the introduction of multislice computed tomography 
(MSCT). The newer generation CT scanners have finally met temporal and spatial 
resolution requirements for clinical use and have provided the base for combination 
with complementary modalities into hybrid imaging.  
Advances in image processing software and the advent of hybrid scanners 
have further paved the way for fusion of image data sets from different modalities. 
This technology avoids mental integration of functional and morphological images 
and facilitates a comprehensive interpretation of the combined data sets. Particularly 
in patients with CAD, by revealing the burden of anatomic coronary disease and its 
physiologic relevance, the hybrid approach can provide noninvasively unique 
information that may help to improve diagnosis and management. First pioneering 
attempts of image fusion were promising (2) but their widespread use was precluded 
by issues of insufficient image resolution, the lack of dedicated fusion software, and 
often tedious and time-consuming image processing. Today, hardware and software 
developments have significantly improved hybrid imaging. Particularly, the creation of 
dedicated fusion software packages that are now commercially available have helped 
to simplify image fusion(3) and therefore facilitate its implementation in clinical 
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practice. Thus, hybrid imaging is becoming more and more available in specialized 
centers, however, data on its clinical usefulness remain scarce. 
In the present issue of the Journal of Nuclear Cardiology, Santana et al. report 
on their clinical experience with hybrid imaging using 16- and 64-slice CT 
angiography (CTA) and myocardial perfusion imaging (MPI) with single photon 
emission computed tomography (SPECT) or positron emission tomography (PET) 
(the latter with 82-Rubidium) in a series of 50 patients (4). The use of fused images 
improved sensitivity and particularly specificity for diagnosing significant CAD 
compared to MPI alone and compared to the side-by-side analysis of MPI and CTA. 
The reference standard was invasive coronary angiography (ICA) and significant 
CAD was defined as at least one stenosis with ≥50% obstruction. Although these 
single point statistics failed to reach statistical significance the comparison of 
diagnostic performance using receiver operating charactersitics (ROC) statistics 
yielded superiority of fusion imaging over the other methods. This diagnostic impact 
is further underscored by the fact that the fusion images led to a modification of the 
initial interpretation in 28% of the cases. Finally, the incremental value of hybrid 
imaging compared to side-by-side analysis seemed to be confined to patients with 
multivessel disease, where a 17% increase in sensitivity was noted. 
With these important results Santana and coworkers build on existing 
experiences with hybrid imaging (5). The present observations emphasize the 
incremental diagnostic value of hybrid imaging in several clinical scenarios. On one 
hand, in low risk populations fusion imaging increases the confidence for ruling out 
CAD as reflected by the higher normalcy rate reported by Santana et al. This is 
particularly helpful in a ”stepwise” CAD evaluation approach where the first study has 
yielded equivocal results and a second study is needed to rule out disease with final 
certainty. So far many of these patients end up being referred for ICA, while hybrid 
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imaging now offers a substantially improved diagnostic confidence resulting in less 
equivocal findings which may allow to greatly reduce the number of patients  
unnecessarily exposed to the risks of invasive procedures (6). In patients with 
multivessel disease, on the other hand, the use of hybrid imaging may provide 
important comprehensive evaluation. In fact, patients with multivessel disease who 
usually are older than the population mentioned above, have more jeopardized 
myocardium and impaired left ventricular function as well as higher risk for 
cardiovascular events. The optimal appreciation of patients with multivessel disease 
is therefore very important to allow for timely and appropriate treatment. The use of 
hybrid imaging in these patients may not only improve diagnostic accuracy, but may 
also (by combination with different tracers) enable evaluation of hemodynamic 
relevance of coronary stenoses and assessment of viability in territories subtended 
by occluded arteries. Santana and colleagues demonstrate, that particularly in 
patients with multivessel disease the value of fusion images lies beyond the simple 
addition of a further diagnostic study. This value originates from the accurate spatial 
association of perfusion defects and coronary stenoses, which allows assigning 
hemodynamic properties to even small vessels, and is underscored by the 28% rate 
of changes in diagnostic impression compared to the side-by-side interpretation. 
Ultimately, this completely noninvasive comprehensive approach to CAD allows to 
obtain important information prior to any invasive procedure, and to stratify patients 
to their appropriate treatment strategy.  
An irritating problem when evaluating the diagnostic performance of 
comprehensive hybrid technologies is the lack of an appropriate gold standard. 
Although ICA is widely accepted as the gold standard for CAD assessment (and as 
such was used in the study by Santana et al.) it remains purely morphologic and 
lacks information on hemodynamic severity of coronary lesions. Intrinsically, when 
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comparing a method for assessing coronary morphology and myocardial perfusion 
(i.e. hybrid technique) with a purely morphologic gold standard (i.e. ICA) an imperfect 
match is unavoidable by nature of the tests used. Conversely, the finding that adding 
CTA to MPI improves accuracy is not surprising using the gold standard of ICA, as a 
morphologic test compares better to another morphologic test. For instance, if an 
intermediate stenosis (i.e. 50-70% stenosis on ICA) does not cause ischemia, it turns 
into a false negative finding, although in fact this stenosis is most likely 
hemodynamically irrelevant. By adding CTA which then confirms an intermediate 
lesion this turns into a true positive finding. Paradoxically, this contradicts the wisdom 
that functional assessment is important and adds important diagnostic information to 
CAD evaluation. However, the incremental information is lost if the gold standard is 
ICA. It is impossible that adding MPI to CTA increases the clinical information if any 
information from MPI is overruled by CTA. This conceptual issue is the fundamental 
problem with diagnostic studies using hybrid technology and future studies should 
aim at using more complex or combined gold standards such as for example ICA 
with fractional flow reserve measurements or combination of ICA and nuclear 
techniques. Ultimately, the best metric against which these techniques will have to 
prove their validity will probably be outcome and very recent data support that 
combined non-invasive anatomical and functional assessment by use of SPECT with 
CTA may allow improved risk stratification (7). 
In conclusion, hybrid imaging combining nuclear and CT has risen as a new 
and attractive cardiac imaging modality. The improvements in software and hardware 
have greatly simplified the use of this technique as evidenced by the fact that in the 
study by Santana et al. different centers with different modalities (SPECT and PET) 
and different generations of CT scanners (16- and 64-slices) were successful. This 
will help to further promote its clinical application. However, many questions as to the 
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real clinical usefulness of hybrid imaging still remain unanswered and further 
research should aim at assessing the impact of hybrid imaging on clinical decision 
making and outcome. In the near future, hybrid technology may play an important 
role in the assessment and management of patients with heart disease due to its 
comprehensive and noninvasive nature. Furthermore, the unique potential to enable 
identification of high-risk plaques using fusion of morphology and biology with 
molecularly targeted PET imaging is a further – although probably not so near – 
future perspective that should encourage continuing research in this field.  
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